News
| 3 min read
Researchers developed a highly tolerable oral antiviral against orthoparamyxoviruses like measles and human parainfluenza virus types 1 and 3.
| 3 min read
Scientists at Johns Hopkins used a whole-body imaging technique to track where therapeutic cells go after injection
| 3 min read
Trained on more than 30,000 tumor genomes, MutationProjector offers drug developers a broader framework for connecting cancer genetics to therapy outcomes.
| 4 min read
FDA approvals, pharma deals, and genetic testing advancements led the news this week.
| 4 min read
New regulatory frameworks, shifting incentives, and pragmatic trial designs could finally move patient engagement from rhetoric to reality.
| 3 min read
Using an unbiased molecular screen, researchers found a new gene that could be targeted to treat fragile X syndrome.
| 3 min read
This year’s New Product Award winners reflect growing demand for tools that improve throughput, reproducibility, and hands-free operation in the lab.
| 3 min read
As the field moves from fecal transplants toward defined bacterial consortia, the technical gaps in design, analytics, and co-cultivation are coming into sharper focus.
| 4 min read
FDA approvals, pharma deals, and more led the news this week.
| 5 min read
A $15 million international study is investigating patients in long-term remission to understand whether lupus can truly switch off — and what that reveals about the immune system.
| 5 min read
Endometriosis is still largely managed with pain relief, hormones, and surgery, but a new precision peptide therapy seeks to directly target the underlying lesion biology.
| 5 min read
Despite rapid therapeutic advances in sickle cell disease, from red blood cell exchange to gene therapies, delivery remains constrained by infrastructure, geography, and care fragmentation.
